Gu, Xiaoping <br/><br/>
Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.  [electronic resource] 

 -  Anesthesia and analgesia  Aug 2011 
 - 405-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-7598 
<br/><br/><label>Standard No.: </label>10.1213/ANE.0b013e31821d1062  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Behavior, Animal--drug effects<br/>Cells, Cultured<br/>Hot Temperature<br/>Indoles--administration & dosage<br/>Injections, Spinal<br/>Male<br/>Mice<br/>Mice, Inbred C3H<br/>Neoplasm Transplantation<br/>Neoplasms, Experimental--complications<br/>Pain Measurement--drug effects<br/>Pain, Intractable--drug therapy<br/>Phosphorylation<br/>RNA, Messenger--biosynthesis<br/>Receptor, Cannabinoid, CB2--agonists<br/>Receptors, G-Protein-Coupled--drug effects<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>Reverse Transcriptase Polymerase Chain Reaction